An ecological analysis of pertussis disease in Minnesota, 2009-2013

Epidemiology and Infection

Volumn 144, Issue 4, 2016, Pages 847-855

  Iroh Tam, P Y ^a   Menk, J S ^a   Hughes, J ^b   Kulasingam, S L ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bordetella pertussis; pertussis (whooping cough); respiratory infections; spatial modelling; vaccine preventable diseases

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CHILD; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HOUSEHOLD; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MATERNAL CARE; NEWBORN; PERTUSSIS; PREVALENCE; PUBLIC HEALTH; RISK ASSESSMENT; UNITED STATES; URBAN POPULATION; URBAN RURAL DIFFERENCE; BAYES THEOREM; MICROBIOLOGY; MINNESOTA; POISSON DISTRIBUTION; PRESCHOOL CHILD; RISK FACTOR; SEASON; SPATIAL ANALYSIS; STATISTICAL MODEL; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; AGED; BAYES THEOREM; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; LINEAR MODELS; MINNESOTA; POISSON DISTRIBUTION; RISK FACTORS; SEASONS; SPATIAL ANALYSIS; WHOOPING COUGH; YOUNG ADULT;

EID: 84940703663     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268815002046     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older-Advisory Committee on Immunization Practices (ACIP), 2012. Morbidity and Mortality Weekly Report 2012; 61: 468-470.
2. Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics 2011; 3: 183-188.
3. Centers for Disease Control and Prevention. Pertussis (whooping cough). 2012 (http://www.cdc.gov/pertussis/outbreaks/about.html). Accessed 5 November 2014.
4. MDH. Pertussis (whooping cough). 2012 (http://www. health.state.mn.us/divs/idepc/diseases/pertussis/index.html). Accessed 5 November 2014.
5. Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiology and Infection 2014; 142: 672-684.
6. Smith PJ, Chu SY, Barker LE. Children who have received no vaccines: who are they and where do they live? Pediatrics 2004; 114: 187-195.
7. Atwell JE, et al. Nonmedical vaccine exemptions and pertussis in California, 2010. Pediatrics 2013; 132: 624-630.
8. Glanz JM, et al. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Pediatrics 2009; 123: 1446-1451.
9. Koepke R, et al. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidlywaning immunity and difference in effectiveness by Tdap brand. Journal of Infectious Diseases 2014; 210: 942-953.
10. Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clinical Infectious Diseases 2012; 54: 1730-1735.
11. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clinical Infectious Diseases 2011; 52: 157-162.
12. Healy CM, et al. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatric Infectious Disease Journal 2015; 34: 22-26.
13. Walter EB, et al. Cocooning infants: Tdap immunization for new parents in the pediatric office. Academic Pediatrics 2009; 9: 344-347.
14. Castagnini LA, et al. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clinical Infectious Diseases 2012; 54: 78-84.
15. Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clinical Infectious Diseases 2013; 56: 539-544.
16. Tiensin T, et al. Ecologic risk factor investigation of clusters of avian influenza A (H5N1) virus infection in Thailand. Journal of Infectious Diseases 2009; 199: 1735-1743.
17. Wolf ER, et al. Impact of a pertussis epidemic on infant vaccination in Washington state. Pediatrics 2014; 134: 456-464.
18. Duffy E, Shea K. Effect of county-level pertussis vaccine coverage on county-level pertussis incidence rates in California during the 2010 pertussis epidemic. Poster, ID Week. San Diego, CA, 2012.
19. US Census Bureau (http://factfinder2.census.gov/faces/nav/jsf/pages/index.xhtml). Accessed 22 April 2014.
20. Minnesota Department of Health (http://www.health. state.mn.us/pertussis). Accessed 22 April 2014.
21. Minnesota Geospatial Information Office (http://www. mngeo.state.mn.us/chouse/metalong.html#admin). Accessed 5 November 2014.
22. Ingram DD, Franco SJ. NCHS urban-rural classification scheme for counties. Vital Health Statistics 2012; 2.
23. Smith LA, et al. Rethinking race/ethnicity, income, and childhood asthma: racial/ethnic disparities concentrated among the very poor. Public Health Reports 2005; 120: 109-116.
24. Salmon DA, Siegel AW. Religious and philosophical exemptions from vaccination requirements and lessons learned from conscientious objectors from conscription. Public Health Reports 2001; 116: 289-295.
25. Hegde V, Dhurandhar NV. Microbes and obesity-interrelationship between infection, adipose tissue and the immune system. Clinical Microbiology and Infection 2013; 19: 314-320.
26. Hughes J, Haran M. Dimension reduction and alleviation of confounding for spatial generalized linear mixed models. Journal of the Royal Statistical Society, Series B 2013; 75: 139-159.
27. Clayton DG, Bernardinelli L, Montomoli C. Spatial correlation in ecological analysis. International Journal of Epidemiology 1993; 22: 1193-1202.
28. Hughes J. ngspatial: A package for fitting the centered autologistic and sparse spatial generalized linear mixed models for areal data. 2014. (http://www.biostat. umn.edu/-johnh/pdf/ngspatial.pdf). Accessed 29 October 2014.
29. Daley MF, et al. Human papillomavirus vaccination practices: A survey of US physicians 18 months after licensure. Pediatrics 2010; 126: 425-433.
30. Kempe A, et al. Adoption of rotavirus vaccination by pediatricians and family medicine physicians in the United States. Pediatrics 2009; 124: e809-816.
31. Hull BP, McIntyre PB, Sayer GP. Factors associated with low uptake of measles and pertussis vaccines-an ecologic study based on the Australian Childhood Immunisation Register. Australian and New Zealand Journal of Public Health 2001; 25: 405-410.
32. Forrest JM, Burgess MA, McIntyre PB. Factors influencing vaccination uptake. Workshop report. Current Australian research on the behavioural, social and demographic factors influencing immunisation, Royal Alexandra Hospital for Children, Sydney, March 1998. Communicable diseases intelligence 2000; 24: 51-53.
33. Healy CM, et al. Pertussis serostatus among neonates born to Hispanic women. Clinical Infectious Diseases 2006; 42: 1439-1442.
34. Dempsey A, et al. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine 2011; 29: 528-534.
35. Hersh BS, et al. The geographic distribution of measles in the United States, 1980 through 1989. Journal of the American Medical Association 1992; 267: 1936-1941.
36. Bockova J, et al. Respiratory syncytial virus infection in Navajo and White Mountain Apache children. Pediatrics 2002; 110: e20.
37. Wingfield T, et al. The seasonality of tuberculosis, sunlight, vitamin D, and household crowding. Journal of Infectious Diseases 2014; 210: 774-783.
38. Delabre RM, et al. Risk factors of pandemic influenza A/H1N1 in a prospective household cohort in the general population: results from the CoPanFlu-France cohort. Influenza and Other Respiratory Viruses 2015; 9: 43-50.
39. Laskowski M, et al. The impact of demographic variable on disease spread: influenza in remote communities. Nature 2011; 1: 1-7.